Cargando…

A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma

Detalles Bibliográficos
Autores principales: Liu, Yang, Duan, Wenbing, Huang, Xiaojun, Lu, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474885/
https://www.ncbi.nlm.nih.gov/pubmed/37662884
http://dx.doi.org/10.2478/jtim-2023-0097
_version_ 1785100601547292672
author Liu, Yang
Duan, Wenbing
Huang, Xiaojun
Lu, Jin
author_facet Liu, Yang
Duan, Wenbing
Huang, Xiaojun
Lu, Jin
author_sort Liu, Yang
collection PubMed
description
format Online
Article
Text
id pubmed-10474885
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-104748852023-09-03 A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma Liu, Yang Duan, Wenbing Huang, Xiaojun Lu, Jin J Transl Int Med Letter to Editor De Gruyter 2023-09-02 /pmc/articles/PMC10474885/ /pubmed/37662884 http://dx.doi.org/10.2478/jtim-2023-0097 Text en © 2023 Yang Liu, Wenbing Duan, Xiaojun Huang, Jin Lu, published by De Gruyter on behalf of Scholar Media Publishing https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License.
spellingShingle Letter to Editor
Liu, Yang
Duan, Wenbing
Huang, Xiaojun
Lu, Jin
A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma
title A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma
title_full A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma
title_fullStr A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma
title_full_unstemmed A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma
title_short A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma
title_sort first case report of using chimeric antigen receptor t-cell immunotherapy to treat high-risk smoldering multiple myeloma
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474885/
https://www.ncbi.nlm.nih.gov/pubmed/37662884
http://dx.doi.org/10.2478/jtim-2023-0097
work_keys_str_mv AT liuyang afirstcasereportofusingchimericantigenreceptortcellimmunotherapytotreathighrisksmolderingmultiplemyeloma
AT duanwenbing afirstcasereportofusingchimericantigenreceptortcellimmunotherapytotreathighrisksmolderingmultiplemyeloma
AT huangxiaojun afirstcasereportofusingchimericantigenreceptortcellimmunotherapytotreathighrisksmolderingmultiplemyeloma
AT lujin afirstcasereportofusingchimericantigenreceptortcellimmunotherapytotreathighrisksmolderingmultiplemyeloma
AT liuyang firstcasereportofusingchimericantigenreceptortcellimmunotherapytotreathighrisksmolderingmultiplemyeloma
AT duanwenbing firstcasereportofusingchimericantigenreceptortcellimmunotherapytotreathighrisksmolderingmultiplemyeloma
AT huangxiaojun firstcasereportofusingchimericantigenreceptortcellimmunotherapytotreathighrisksmolderingmultiplemyeloma
AT lujin firstcasereportofusingchimericantigenreceptortcellimmunotherapytotreathighrisksmolderingmultiplemyeloma